awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35196366-A0BD843D-0FC1-4E38-8A0F-01B292AB3F46
Q35196366-A0BD843D-0FC1-4E38-8A0F-01B292AB3F46
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35196366-A0BD843D-0FC1-4E38-8A0F-01B292AB3F46
Treating coronary disease and the impact of endothelial dysfunction.
P2860
Q35196366-A0BD843D-0FC1-4E38-8A0F-01B292AB3F46
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35196366-A0BD843D-0FC1-4E38-8A0F-01B292AB3F46
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5763a7db458606102245eeabeaa6716c7df1fad2
P2860
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.